Medicare Enrolled
Dr. Mylene Go, M.D
Hematology & Oncology · Chester, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Go from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Go?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Go
Dr. Mylene Go is a hematology & oncology specialist in Chester, PA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Go performed 85,561 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Go received a total of $8,444 from 75 pharmaceutical and/or device companies across 496 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Go is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 8% volume in PA
$8,444 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗85,561
Medicare services
Top 8% in PA for hematology & oncology
Not available
Unique patients (not deduplicated)
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
55,500 | $1 | $3 |
| Pembrolizumab injection (Keytruda) | 9,400 | $43 | $65 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
5,850 | $0 | $3 |
| Denosumab injection (Prolia/Xgeva) | 4,200 | $18 | $50 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
2,500 | $6 | $50 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
1,580 | $6 | $25 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
951 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
925 | $8 | $30 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
833 | $105 | $199 |
| Anti-nausea injection (Aloxi/palonosetron) | 780 | $1 | $51 |
| Pegfilgrastim-cbqv injection An injection of pegfilgrastim-cbqv, a biosimilar medication, administered at a dose of 0.5 mg. |
372 | $107 | $700 |
| Anti-nausea injection (ondansetron/Zofran) | 360 | $0 | $2 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
317 | $12 | $76 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
255 | $14 | $77 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
224 | $118 | $301 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
193 | $2 | $100 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
121 | $26 | $95 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
118 | $76 | $150 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
118 | $67 | $152 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
97 | $57 | $201 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
86 | $148 | $362 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
81 | $25 | $200 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
76 | $58 | $150 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
72 | $64 | $150 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
70 | $132 | $299 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
68 | $1 | $13 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
62 | $10 | $25 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
62 | $1 | $10 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
60 | $18 | $100 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
49 | $1 | $10 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
42 | $42 | $82 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
33 | $111 | $250 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
31 | $11 | $100 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
30 | $50 | $250 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
25 | $18 | $95 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
20 | $20 | $75 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
65.6% high complexity
31.6% medium
2.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,444
Total received (2018-2024)
Avg $1,206/year across 7 years
Top 24% in PA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
75
Companies
496
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,219
2023
$1,423
2022
$972
2021
$304
2020
$181
2019
$2,204
2018
$2,142
Payments by company (2024)
Immunocore Limited
$120
PFIZER INC.
$86
E.R. Squibb & Sons, L.L.C.
$85
Novartis Pharmaceuticals Corporation
$81
GlaxoSmithKline, LLC.
$69
ABBVIE INC.
$58
Merck Sharp & Dohme LLC
$54
AstraZeneca Pharmaceuticals LP
$52
Celgene Corporation
$50
Incyte Corporation
$47
Genentech USA, Inc.
$37
Ipsen Biopharmaceuticals, Inc
$35
SOBI, INC
$35
Daiichi Sankyo Inc.
$33
Rigel Pharmaceuticals, Inc.
$33
Gilead Sciences, Inc.
$30
Alexion Pharmaceuticals, Inc.
$25
Bayer Healthcare Pharmaceuticals Inc.
$20
Agios Pharmaceuticals, Inc.
$19
Genmab U.S., Inc.
$19
Deciphera Pharmaceuticals Inc.
$18
Kite Pharma, Inc.
$18
Tempus AI, Inc
$18
Geron Corporation
$18
SERVIER PHARMACEUTICALS LLC
$17
BeiGene USA, Inc.
$17
MorphoSys, US Inc.
$17
TerSera Therapeutics LLC
$17
Lilly USA, LLC
$17
Eisai Inc.
$16
Stemline Therapeutics Inc.
$16
Janssen Biotech, Inc.
$16
Astellas Pharma US Inc
$14
Exelixis Inc.
$14
Top 3 companies account for 23.8% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$1,028
Genentech USA, Inc.
$537
Janssen Biotech, Inc.
$479
PFIZER INC.
$386
Novartis Pharmaceuticals Corporation
$376
Celgene Corporation
$353
Lilly USA, LLC
$325
Ipsen Biopharmaceuticals, Inc
$270
AstraZeneca Pharmaceuticals LP
$259
Eisai Inc.
$252
Exelixis Inc.
$180
TESARO, Inc.
$180
GENZYME CORPORATION
$178
Pharmacyclics LLC, An AbbVie Company
$177
Gilead Sciences, Inc.
$177
Incyte Corporation
$170
Janssen Pharmaceuticals, Inc
$168
Merck Sharp & Dohme LLC
$164
Astellas Pharma US Inc
$144
Seagen Inc.
$136
GlaxoSmithKline, LLC.
$129
Merck Sharp & Dohme Corporation
$128
Immunocore Limited
$120
Karyopharm Therapeutics Inc.
$117
ABBVIE INC.
$114
Puma Biotechnology, Inc.
$91
Rigel Pharmaceuticals, Inc.
$87
Boehringer Ingelheim Pharmaceuticals, Inc.
$85
Bayer HealthCare Pharmaceuticals Inc.
$84
Kite Pharma, Inc.
$82
Amgen Inc.
$79
MorphoSys, US Inc.
$65
EMD Serono, Inc.
$64
Bayer Healthcare Pharmaceuticals Inc.
$58
Seattle Genetics, Inc.
$56
Kyowa Kirin, Inc.
$56
Regeneron Healthcare Solutions, Inc.
$53
Teva Pharmaceuticals USA, Inc.
$53
Apellis Pharmaceuticals, Inc.
$50
Takeda Pharmaceuticals U.S.A., Inc.
$48
Genmab U.S., Inc.
$47
Daiichi Sankyo Inc.
$46
ASD SPECIALTY HEALTHCARE, LLC
$45
EISAI INC.
$45
AVEO Pharmaceuticals, Inc.
$41
Dova Pharmaceuticals
$40
Spectrum Pharmaceuticals Inc.
$40
TerSera Therapeutics LLC
$37
Agios Pharmaceuticals, Inc.
$35
SOBI, INC
$35
Stemline Therapeutics Inc.
$32
SERVIER PHARMACEUTICALS LLC
$32
INSYS Therapeutics Inc
$30
BeiGene USA, Inc.
$29
Pharmacyclics LLC, an AbbVie Company
$25
Alexion Pharmaceuticals, Inc.
$25
G1 Therapeutics, Inc.
$25
AbbVie, Inc.
$19
Deciphera Pharmaceuticals Inc.
$18
Tempus AI, Inc
$18
Geron Corporation
$18
MEDIVATION FIELD SOLUTIONS LLC
$17
Pharmacosmos Therapeutics Inc.
$17
Organon LLC
$16
Tolmar, Inc.
$16
Mirati Therapeutics, Inc.
$15
Servier Pharmaceuticals LLC
$15
Foundation Medicine, Inc.
$15
ARRAY BIOPHARMA INC
$15
EUSA Pharma (US) LLC
$14
Fresenius Kabi USA, LLC
$13
AMAG Pharmaceuticals, Inc.
$13
Acrotech Biopharma LLC
$13
Lexicon Pharmaceuticals, Inc.
$13
AbbVie Inc.
$13
Top 3 companies account for 24.2% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALUNBRIG · ASPARLAS · AUGTYRO · Abraxane · Alecensa · Aliqopa · Avastin · BELEODAQ · BENDEKA · BLENREP · BOSULIF · BRUKINSA · Balversa · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CHANTIX · COSELA · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · Empaveli · Enhertu · Epkinly · Erleada · FARESTON · FERAHEME · FOTIVDA · FOUNDATIONONE · Fabhalta · Folotyn · GAZYVA · GILOTRIF · Gazyva · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · INJECTAFER · INLYTA · Imbruvica · Inrebic · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kabiven · Kadcyla · Kyprolis · LIBTAYO · LUPRON DEPOT · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · Nerlynx · Nplate · OJJAARA · ONTRUZANT · OPDIVO · OPDUALAG · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PYRUKYND · Padcev · Perjeta · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · ROLVEDON · RYTELO · Revlimid · Rezlidhia · SANDOSTATIN · SCEMBLIX · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYNDROS · Somatuline Depot · Stivarga · Sylvant · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TEVIMBRA · TUKYSA · Tavalisse · Tazverik · Tibsovo · Tivdak · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · Venclexta · XALKORI · XARELTO · XPOVIO · XT CDX · XTANDI · Xermelo · Xofigo · Yescarta · ZEJULA · ZOLADEX
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
267
County median income
$88,576
Nearest hospital to ZIP centroid (approximate)
CROZER CHESTER MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Go is a mixed practice specialist, with above-average Medicare volume (top 8% in PA), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Go experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Go performed 55,500 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Go receive payments from pharmaceutical companies?
Yes. Dr. Go received a total of $8,444 from 75 companies across 496 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Go's costs compare to other hematology & oncology specialists in Chester?
Dr. Go's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Go) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Chester
Browse hematology & oncology specialists in Chester ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in PA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in PA
Which PA hematology & oncology specialists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology